Background: From historical times termination of pregnancy was practiced with or without legal and social sanctions. Over the last few years, induced abortions have gained more popularity because of safe techniques and medications available. Induced abortion means willful termination of pregnancy before the period of viability. Medical abortion in the second trimester with misoprostol alone has been shown to be affective, although in comparison with the combination of mifepristone and misoprostol, misoprostol-only protocols have required higher doses, side effects are more common and the time to complete the abortion is longer. Methods: Total of 50 eligible women were enrolled for this study and were divided in two groups of 25 each of the case group and control group. This study was conducted in the Dhiraj General Hospital, Piparia, Waghodia. Women in the case group were given Tablet Mifepristone (200 mg) orally followed by Tablet Misoprostol (200 mcg) vaginally after 24 hours which may be repeated every 6 hrs till 5 doses. Women in control group were given Tablet Misoprostol (200 mcg) vaginally which may be repeated every 6 hrs till 5 doses. Results: The combination of mifepristone and misoprostol is now an established and highly effective and safe method for medical method second trimester abortion. The combination of mifepristone with misoprostol significantly reduces the abortion to induction interval and also have fewer side effects and complications and also reduces the dose of misoprostol. Where mifepristone is not available or affordable, misoprostol alone has also been shown to be effective, although a higher total dose is needed and efficacy is lower than for the combined regimen. Therefore, whenever possible, the combined regimen should be used. Conclusions: Mifepristone followed by misoprostol was more effective and has a shorter IAI and fewer side effects. [Int J Reprod Contracept Obstet Gynecol 2013; 2(3.000): 315-319

Enteric fever caused by Salmonella typhi resistant to all the standard first-line antibiotics is emerging as a major problem in developing countries. Fifteen such culture-proven cases were treated with ceftriaxone (6), cefotaxime (5) or ciprofloxacin (4). The earliest defervescence occurred with ceftriaxone (mean 3.3 days). Clinical cures were obtained with all three drugs with only one child having a relapse. Ciprofloxacin, by virtue of its cost and an oral route of administration, is the ideal choice in a developing country.

Although there is little doubt that the response of young infants to bronchodilators is less good than that of older children, I think that in the acute stage a substantial number of them do benefit and it is worth a trial.References Konig, P. (1978). Treatment of severe attacks of asthma in children with nebulised B2 adrenergic agents. Annals of Allergy, 40, 185-188. Radford, M. (1975 We were interested to hear of Dr Konig's experience with nebulised salbutamol in children under one year. We accept that all our studies were carried out during the recovery phase but we have not found that any child under one year has obtained any useful, clinical benefit from nebulised salbutamol when administered in the acute phase. Since our paper was published, two children between the ages of 12 and 18 months have responded well, and we have since heard of another who apparently obtained benefit by age 11 months. We still recommend that salbutamol be given to all wheezing children over one year but think it unlikely that many children younger that this will respond to this form of treatment.